Back
Results - Announcements
Sales rise 262.95% to Rs 33.21 crore
Oxygenta Pharmaceutical reports standalone net loss of Rs 3.93 crore in the December 2024 quarter
15-Feb-2025, 07:32
Net Loss of Oxygenta Pharmaceutical reported to Rs 3.93 crore in the quarter ended December 2024 as against net loss of Rs 3.78 crore during the previous quarter ended December 2023. Sales rose 262.95% to Rs 33.21 crore in the quarter ended December 2024 as against Rs 9.15 crore during the previous quarter ended December 2023.
Net Loss of Oxygenta Pharmaceutical reported to Rs 3.93 crore in the quarter ended December 2024 as against net loss of Rs 3.78 crore during the previous quarter ended December 2023. Sales rose 262.95% to Rs 33.21 crore in the quarter ended December 2024 as against Rs 9.15 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 33.21 | 9.15 | 263 |
| OPM % | -13.10 | -27.10 | - |
| PBDT | -4.25 | -2.81 | -51 |
| PBT | -4.96 | -3.50 | -42 |
| NP | -3.93 | -3.78 | -4 |
Powered by Capital Market - Live News